3,036
Views
18
CrossRef citations to date
0
Altmetric
Review Articles

Potassium channels and their role in glioma: A mini review

ORCID Icon, , , , &
Pages 76-85 | Received 28 Mar 2019, Accepted 05 Feb 2020, Published online: 09 Mar 2020

References

  • Abdullaev IF, Rudkouskaya A, Mongin AA, Kuo YH. 2010. Calcium-activated potassium channels BK and IK1 are functionally expressed in human gliomas but do not regulate cell proliferation. Plos One 5:e12304.
  • Arvind S, Arivazhagan A, Santosh V, Chandramouli BA. 2012. Differential expression of a novel voltage gated potassium channel–Kv 1.5 in astrocytomas and its impact on prognosis in glioblastoma. Br J Neurosurg 26:16–20.
  • Bai Y, Liao H, Liu T, Zeng X, Xiao F, Luo L, et al. 2013. MiR-296-3p regulates cell growth and multi-drug resistance of human glioblastoma by targeting ether-a-go-go (EAG1). Eur J Cancer 49:710–724.
  • Basrai D, Kraft R, Bollensdorff C, Liebmann L, Benndorf K, Patt S. 2002. BK channel blockers inhibit potassium-induced proliferation of human astrocytoma cells. Neuroreport 13:403–407.
  • Bataveljic D, Nikolic L, Milosevic M, Todorovic N, Andjus PR. 2012. Changes in the astrocytic TQuaporin-4 and inwardly rectifying potassium channel expression in the brain of the amyotrophic lateral sclerosis SOD1(G93A) rat model. Glia 60:1991–2003.
  • Bednarczyk P, Kowalczyk JE, Beręsewicz M, Dołowy K, Szewczyk A, Zabłocka B. 2010. Identification of a voltage-gated potassium channel in gerbil hippocampal mitochondria. Biochem Biophys Res Commun 397:614–620.
  • Benedikt J, Inyushin M, Kucheryavykh YV, Rivera Y, Kucheryavykh LY, Nichols CG, et al. 2012. Intracellular polyamines enhance astrocytic coupling. Neuroreport 23:1021–1025.
  • Bi D, Toyama K, Lemaitre V, Takai J, Fan F, Jenkins DP, et al. 2013. The intermediate conductance calcium-activated potassium channel KCa3.1 regulates vascular smooth muscle cell proliferation via controlling calcium-dependent signaling. J Biol Chem 288:15843–15853.
  • Biedermann B, Skatchkov SN, Brunk I, Bringmann A, Pannicke T, Bernstein HG, et al. 1998. Spermine/spermidine is expressed by retinal glial (Muller) cells and controls distinct K + channels of their membrane. Glia 23:209–220.
  • Bielanska J, Hernandez-Losa J, Moline T, Somoza R, Ramon YCS, Condom E, et al. 2012. Increased voltage-dependent K + channel Kv1.3 and Kv1.5 expression correlates with leiomyosarcoma aggressiveness. Oncol Lett 4:227–230.
  • Boonstra J, Mummery CL, Tertoolen LG, Van Der Saag PT, De Laat SW. 1981. Cation transport and growth regulation in neuroblastoma cells. Modulations of K + transport and electrical membrane properties during the cell cycle. J Cell Physiol 107:75–83.
  • Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann P, Skatchkov SN, et al. 2006. Muller cells in the healthy and diseased retina. Prog Retin Eye Res 25:397–424.
  • Brown BM, Pressley B, Wulff H. 2018. KCa3.1 Channel modulators as potential therapeutic compounds for glioblastoma. Curr Neuropharmacol 16:618–626.
  • Campbell SC, Munoz-Ballester C, Chaunsali L, Mills WR, Yang JH, Sontheimer H, Robel S. 2020. Potassium and glutamate transport is impaired in scar-forming tumor-associated astrocytes. Neurochem Int 133:104628.
  • Capiod T. 2011. Cell proliferation, calcium influx and calcium channels. Biochimie 93:2075–2079.
  • Catacuzzeno L, Aiello F, Fioretti B, Sforna L, Castigli E, Ruggieri P, et al. 2011. Serum-activated K and Cl currents underlay U87-MG glioblastoma cell migration. J Cell Physiol 226:1926–1933.
  • Catacuzzeno L, Franciolini F. 2018. Role of KCa3.1 channels in modulating Ca(2+) oscillations during glioblastoma cell migration and invasion. Int J Mol Sci 19:2970.
  • Cazares-Ordonez V, Pardo LA. 2017. Kv10.1 potassium channel: from the brain to the tumors. Biochem Cell Biol 95:531–536.
  • Cheng Y, Gulbins E, Siemen D. 2011. Activation of the permeability transition pore by Bax via inhibition of the mitochondrial BK channel. Cell Physiol Biochem 27:191–200.
  • Contreras JE, Sanchez HA, Eugenin EA, Speidel D, Theis M, Willecke K, et al. 2002. Metabolic inhibition induces opening of unapposed connexin 43 gap junction hemichannels and reduces gap junctional communication in cortical astrocytes in culture. Proc Natl Acad Sci USA 99:495–500.
  • Corbetta C, Di Ianni N, Bruzzone MG, Patane M, Pollo B, Cantini G, et al. 2019. Altered function of the glutamate-aspartate transporter GLAST, a potential therapeutic target in glioblastoma. Int J Cancer 144:2539–2554.
  • Cronier L, Crespin S, Strale PO, Defamie N, Mesnil M. 2009. Gap junctions and cancer: new functions for an old story. Antioxid Redox Signal 11:323–338.
  • D’Alessandro G, Catalano M, Sciaccaluga M, Chece G, Cipriani R, Rosito M, et al. 2013. KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo. Cell Death Dis 4:e773.
  • D’Alessandro G, Grimaldi A, Chece G, Porzia A, Esposito V, Santoro A, et al. 2016. KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment. Oncotarget 7:30781–30796.
  • Debska-Vielhaber G, Godlewski MM, Kicinska A, Skalska J, Kulawiak B, Piwonska M, et al. 2009. Large-conductance K + channel openers induce death of human glioma cells. J Physiol Pharmacol 60:27–36.
  • Djukic B, Casper KB, Philpot BD, Chin LS, McCarthy KD. 2007. Conditional knock-out of Kir4.1 leads to glial membrane depolarization, inhibition of potassium and glutamate uptake, and enhanced short-term synaptic potentiation. J Neurosci 27:11354–11365.
  • Felipe A, Bielanska J, Comes N, Vallejo A, Roig S, Ramon YCS, Condom E, et al. 2012. Targeting the voltage-dependent K(+) channels Kv1.3 and Kv1.5 as tumor biomarkers for cancer detection and prevention. Curr Med Chem 19:661–674.
  • Ge L, Hoa NT, Wilson Z, Arismendi-Morillo G, Kong XT, Tajhya RB, et al. 2014. Big Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy. Int Immunopharmacol 22:427–443.
  • Hao X, Li X. 2015. The knockdown of TASK-1 channels improved the proliferation of N2A cells. J Mol Neurosci 55:314–317.
  • Heuser K, Eid T, Lauritzen F, Thoren AE, Vindedal GF, Tauboll E, et al. 2012. Loss of perivascular Kir4.1 potassium channels in the sclerotic hippocampus of patients with mesial temporal lobe epilepsy. J Neuropathol Exp Neurol 71:814–825.
  • Hoa NT, Ge L, Martini F, Chau V, Ahluwalia A, Kruse CA, Jadus MR. 2016. Temozolomide induces the expression of the glioma Big Potassium (gBK) ion channel, while inhibiting fascin-1 expression: possible targets for glioma therapy. Expert Opin Ther Targets 20:1155–1167.
  • Hong X, Sin WC, Harris AL, Naus CC. 2015. Gap junctions modulate glioma invasion by direct transfer of microRNA. Oncotarget 6:15566–15577.
  • Hu L, Li LL, Lin ZG, Jiang ZC, Li HX, Zhao SG, Yang KB. 2014. Blockage of potassium channel inhibits proliferation of glioma cells via increasing reactive oxygen species. Oncol Res 22:57–65.
  • Huang MH, Huang YM, Wu SN. 2015. The inhibition by oxaliplatin, a platinum-based anti-neoplastic agent, of the activity of intermediate-conductance Ca(2)(+)-activated K(+) channels in human glioma cells. Cell Physiol Biochem 37:1390–1406.
  • Huang X, Jan LY. 2014. Targeting potassium channels in cancer. J Cell Biol 206:151–162.
  • Huang L, Li B, Li W, Guo H, Zou F. 2009. ATP-sensitive potassium channels control glioma cells proliferation by regulating ERK activity. Carcinogenesis 30:737–744.
  • Huang L, Li B, Tang S, Guo H, Li W, Huang X, et al. 2015. Mitochondrial KATP channels control glioma radioresistance by regulating ROS-induced ERK activation. Mol Neurobiol 52:626–637.
  • Inyushin M, Kucheryaykh Y, Kucheryavykh L, Sanabria P, Jimenez-Rivera C, Struganova I, et al. 2010. Membrane potential and pH-dependent accumulation of decynium-22 (1,1'-diethyl-2,2'-cyanine iodide) flourencence through OCT transporters in astrocytes. Bol Asoc Med P R 102:5–12.
  • Jang SH, Choi SY, Ryu PD, Lee SY. 2011. Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo. Eur J Pharmacol 651:26–32.
  • Jehle J, Schweizer PA, Katus HA, Thomas D. 2011. Novel roles for hERG K(+) channels in cell proliferation and apoptosis. Cell Death Dis 2:e193–e193.
  • Kinboshi M, Shimizu S, Mashimo T, Serikawa T, Ito H, Ikeda A, et al. 2019. Down-regulation of astrocytic Kir4.1 channels during the audiogenic epileptogenesis in leucine-rich glioma-inactivated 1 (Lgi1) mutant rats. Int J Mol Sci 20:E1013.
  • Klumpp L, Sezgin EC, Skardelly M, Eckert F, Huber SM. 2018. KCa3.1 channels and glioblastoma: in vitro studies. Curr Neuropharmacol 16:627–635.
  • Kofuji P, Biedermann B, Siddharthan V, Raap M, Iandiev I, Milenkovic I, et al. 2002. Kir potassium channel subunit expression in retinal glial cells: implications for spatial potassium buffering. Glia 39:292–303.
  • Krauss M, Langnaese K, Richter K, Brunk I, Wieske M, Ahnert-Hilger G, et al. 2006. Spermidine synthase is prominently expressed in the striatal patch compartment and in putative interneurones of the matrix compartment. J Neurochem 97:174–189.
  • Kucheryavykh LY, Benedikt J, Cubano LA, Skatchkov SN, Bukauskas FF, Kucheryavykh YV. 2017. Polyamines preserve connexin 43-mediated gap junctional communication during intracellular hypercalcemia and acidosis. Neuroreport 28:208–213.
  • Kucheryavykh YV, Kucheryavykh LY, Nichols CG, Maldonado HM, Baksi K, Reichenbach A, et al. 2007. Downregulation of Kir4.1 inward rectifying potassium channel subunits by RNAi impairs potassium transfer and glutamate uptake by cultured cortical astrocytes. Glia 55:274–281.
  • Kucheryavykh LY, Rolon-Reyes K, Kucheryavykh YV, Skatchkov S, Eaton MJ, Sanabria P, et al. 2014. Glioblastoma development in mouse brain: general reduction of OCTs and mislocalization of OCT3 transporter and subsequent uptake of ASP(+) substrate to the nuclei. J Neurosci Neuroeng 3:3–9.
  • Lastraioli E, Lottini T, Bencini L, Bernini M, Arcangeli A. 2015. hERG1 potassium channels: novel biomarkers in human solid cancers. Biomed Res Int 2015:1–9.
  • Lent R, Azevedo FA, Andrade-Moraes CH, Pinto AV. 2012. How many neurons do you have? Some dogmas of quantitative neuroscience under revision. Eur J Neurosci 35:1–9.
  • Li X, Hu X, Li X, Hao X. 2015. Overexpression of tau downregulated the mRNA levels of Kv channels and improved proliferation in N2A cells. Plos One 10:e0116628.
  • Liu H, Huang J, Peng J, Wu X, Zhang Y, Zhu W, Guo L. 2015. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway. Mol Cancer 14:59.
  • MacFarlane SN, Sontheimer H. 2000. Changes in ion channel expression accompany cell cycle progression of spinal cord astrocytes. Glia 30:39–48.
  • Mesnil M, Crespin S, Avanzo JL, Zaidan-Dagli ML. 2005. Defective gap junctional intercellular communication in the carcinogenic process. Biochim Biophys Acta 1719:125–145.
  • Musa H, Veenstra RD. 2003. Voltage-dependent blockade of connexin40 gap junctions by spermine. Biophys J 84:205–219.
  • Niday Z, Tzingounis AV. 2018. Potassium channel gain of function in epilepsy: an unresolved paradox. Neuroscientist 24:368–380.
  • Olsen ML, Khakh BS, Skatchkov SN, Zhou M, Lee CJ, Rouach N. 2015. New insights on astrocyte ion channels: critical for homeostasis and neuron-glia signaling. J Neurosci 35:13827–13835.
  • Olsen ML, Sontheimer H. 2004. Mislocalization of Kir channels in malignant glia. Glia 46:63–73.
  • Olsen ML, Sontheimer H. 2008. Functional implications for Kir4.1 channels in glial biology: from K + buffering to cell differentiation. J Neurochem 107:589–601.
  • Pardo LA, Stuhmer W. 2014. The roles of K(+) channels in cancer. Nat Rev Cancer 14:39–48.
  • Patt S, Preußat K, Beetz C, Kraft R, Schrey M, Kalff R, et al. 2004. Expression of ether a go-go potassium channels in human gliomas. Neurosci Lett 368:249–253.
  • Peng Y, Wang X, Guo Y, Peng F, Zheng N, He B, et al. 2019. Pattern of cell-to-cell transfer of microRNA by gap junction and its effect on the proliferation of glioma cells. Cancer Sci 110:1947–1958.
  • Preußat K, Beetz C, Schrey M, Kraft R, Wölfl S, Kalff R, Patt S. 2003. Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas. Neurosci Lett 346:33–36.
  • Qi M, Yang X, Zhang F, Lin T, Sun X, Li Y, et al. 2014. ERG rearrangement is associated with prostate cancer-related death in Chinese prostate cancer patients. PLoS One 9:e84959.
  • Rash JE, Yasumura T, Dudek FE, Nagy JI. 2001. Cell-specific expression of connexins and evidence of restricted gap junctional coupling between glial cells and between neurons. J Neurosci 21:1983–2000.
  • Rosa P, Sforna L, Carlomagno S, Mangino G, Miscusi M, Pessia M, et al. 2017. Overexpression of large-conductance calcium-activated potassium channels in human glioblastoma stem-like cells and their role in cell migration. J Cell Physiol 232:2478–2488.
  • Ru Q, Li WL, Xiong Q, Chen L, Tian X, Li CY. 2018. Voltage-gated potassium channel blocker 4-aminopyridine induces glioma cell apoptosis by reducing expression of microRNA-10b-5p. Mol Biol Cell 29:1125–1136.
  • Ru Q, Tian X, Pi MS, Chen L, Yue K, Xiong Q, et al. 2015. Voltagegated K + channel blocker quinidine inhibits proliferation and induces apoptosis by regulating expression of microRNAs in human glioma U87MG cells. Int J Oncol 46:833–840.
  • Ru Q, Tian X, Wu YX, Wu RH, Pi MS, Li CY. 2014. Voltage-gated and ATP-sensitive K + channels are associated with cell proliferation and tumorigenesis of human glioma. Oncol Rep 31:842–848.
  • Ryland KE, Svoboda LK, Vesely ED, McIntyre JC, Zhang L, Martens JR, Lawlor ER. 2015. Polycomb-dependent repression of the potassium channel-encoding gene KCNA5 promotes cancer cell survival under conditions of stress. Oncogene 34:4591–4600.
  • Sala-Rabanal M, Kucheryavykh LY, Skatchkov SN, Eaton MJ, Nichols CG. 2010. Molecular mechanisms of EAST/SeSAME syndrome mutations in Kir4.1 (KCNJ10). J Biol Chem 285:36040–36048.
  • Sala-Rabanal M, Li DC, Dake GR, Kurata HT, Inyushin M, Skatchkov SN, Nichols CG. 2013. Polyamine transport by the polyspecific organic cation transporters OCT1, OCT2, and OCT3. Mol Pharm 10:1450–1458.
  • Sales TT, Resende FFB, Chaves NL, Titze-De-Almeida SS, Báo SN, Brettas ML, Titze-De-Almeida R. 2016. Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide. Oncol Lett 12:2581–2589.
  • Schopf S, Ruge H, Bringmann A, Reichenbach A, Skatchkov SN. 2004. Switch of K + buffering conditions in rabbit retinal Muller glial cells during postnatal development. Neurosci Lett 365:167–170.
  • Shah NH, Aizenman E. 2014. Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration. Transl Stroke Res 5:38–58.
  • Sharifi N, Salmaninejad A, Ferdosi S, Bajestani AN, Khaleghiyan M, Estiar MA, et al. 2016. HER2 gene amplification in patients with prostate cancer: evaluating a CISH-based method. Oncol Lett 12:4651–4658.
  • Shen Z, Yang Q, You Q. 2009. Researches toward potassium channels on tumor progressions. Curr Top Med Chem 9:322–329.
  • Skatchkov SN, Bukauskas FF, Benedikt J, Inyushin M, Kucheryavykh YV. 2015. Intracellular spermine prevents acid-induced uncoupling of Cx43 gap junction channels. Neuroreport 26:528–532.
  • Skatchkov SN, Eaton MJ, Krušek J, Veh R. W, Biedermann B, Bringmann A, et al. 2000. Spatial distribution of spermine/spermidine content and K(+)-current rectification in frog retinal glial (Muller) cells. Glia 31:84–90.
  • Skatchkov SN, Rojas L, Eaton MJ, Orkand RK, Biedermann B, Bringmann A, et al. 2002. Functional expression of Kir 6.1/SUR1-K(ATP) channels in frog retinal Muller glial cells. Glia 38:256–267.
  • Skatchkov SN, Woodbury-Farina MA, Eaton M. 2014. The role of glia in stress: polyamines and brain disorders. Psychiatr Clin North Am 37:653–678.
  • So EC, Lo YC, Chen LT, Kao CA, Wu SN. 2014. High effectiveness of triptolide, an active diterpenoid triepoxide, in suppressing Kir-channel currents from human glioma cells. Eur J Pharmacol 738:332–341.
  • Song MS, Ryu PD, Lee SY. 2017. Kv3.4 is modulated by HIF-1alpha to protect SH-SY5Y cells against oxidative stress-induced neural cell death. Sci Rep 7:2075.
  • Staudacher I, Jehle J, Staudacher K, Pledl HW, Lemke D, Schweizer PA, et al. 2014. HERG K + channel-dependent apoptosis and cell cycle arrest in human glioblastoma cells. Plos One 9:e88164.
  • Stegen B, Butz L, Klumpp L, Zips D, Dittmann K, Ruth P, Huber SM. 2015. Ca2+-activated IK K + channel blockade radiosensitizes glioblastoma cells. Mol Cancer Res 13:1283–1295.
  • Szabo I, Bock J, Grassme H, Soddemann M, Wilker B, Lang F, et al. 2008. Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes. Proc Natl Acad Sci U S A 105:14861–14866.
  • Taglialatela M, Secondo A, Fresi A, Rosati B, Pannaccione A, Castaldo P, et al. 2001. Inhibition of depolarization-induced [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells by some second-generation H(1) receptor antagonists through blockade of store-operated Ca(2+) channels (SOCs). Biochem Pharmacol 62:1229–1238.
  • Thuringer D, Chanteloup G, Boucher J, Pernet N, Boudesco C, Jego G, et al. 2017. Modulation of the inwardly rectifying potassium channel Kir4.1 by the pro-invasive miR-5096 in glioblastoma cells. Oncotarget 8:37681–37693.
  • Tian C, Zhu R, Zhu L, Qiu T, Cao Z, Kang T. 2014. Potassium channels: structures, diseases, and modulators. Chem Biol Drug Des 83:1–26.
  • Tong H, Yu X, Lu X, Wang P. 2015. Downregulation of solute carriers of glutamate in gliosomes and synaptosomes may explain local brain metastasis in anaplastic glioblastoma. Iubmb Life 67:306–311.
  • Turner KL, Honasoge A, Robert SM, McFerrin MM, Sontheimer H. 2014. A proinvasive role for the Ca(2+) -activated K(+) channel KCa3.1 in malignant glioma. Glia 62:971–981.
  • Veeravalli KK, Ponnala S, Chetty C, Tsung AJ, Gujrati M, Rao JS. 2012. Integrin alpha9beta1-mediated cell migration in glioblastoma via SSAT and Kir4.2 potassium channel pathway. Cell Signal 24:272–281.
  • Venturini E, Leanza L, Azzolini M, Kadow S, Mattarei A, Weller M, et al. 2017. Targeting the potassium channel Kv1.3 kills glioblastoma cells. Neurosignals 25:26–38.
  • Vyas VK, Parikh P, Ramani J, Ghate M. 2019. Medicinal chemistry of potassium channel modulators: an update of recent progress (2011–2017). Curr Med Chem 26:2062–2084.
  • Wang J, Li Y, Jiang C. 2015. MiR-133b contributes to arsenic-induced apoptosis in U251 glioma cells by targeting the hERG channel. J Mol Neurosci 55:985–994.
  • Wang HZ, Veenstra RD. 1997. Monovalent ion selectivity sequences of the rat connexin43 gap junction channel. J Gen Physiol 109:491–507.
  • Weaver AK, Bomben VC, Sontheimer H. 2006. Expression and function of calcium-activated potassium channels in human glioma cells. Glia 54:223–233.
  • Weiger TM, Colombatto S, Kainz V, Heidegger W, Grillo MA, Hermann A. 2007. Potassium channel blockers quinidine and caesium halt cell proliferation in C6 glioma cells via a polyamine-dependent mechanism. Biochem Soc Trans 35:391–395.
  • Weiger TM, Hermann A. 2014. Cell proliferation, potassium channels, polyamines and their interactions: a mini review. Amino Acids 46:681–688.
  • Yang KB, Zhao SG, Liu YH, Hu EX, Liu BX. 2009. Tetraethylammonium inhibits glioma cells via increasing production of intracellular reactive oxygen species. Chemotherapy 55:372–380.
  • Yeager M, Nicholson BJ. 1996. Structure of gap junction intercellular channels. Curr Opin Struct Biol 6:183–192.
  • Zhang Y, Zhang P, Chen L, Zhao L, Zhu J, Zhu T. 2019. The long non-coding RNA-14327.1 promotes migration and invasion potential of endometrial carcinoma cells by stabilizing the potassium channel Kca3.1. Onco Targets Ther 12:10287–10297.
  • Zhorov BS. 2011. Interactions of drugs and toxins with permeant ions in potassium, sodium, and calcium channels. Ross Fiziol Zh Im I M Sechenova 97:661–677.
  • Zhu J, Yan J, Thornhill WB. 2014. The Kv1.3 potassium channel is localized to the cis-Golgi and Kv1.6 is localized to the endoplasmic reticulum in rat astrocytes. Febs J 281:3433–3445.
  • Zuniga L, Zuniga R. 2016. Understanding the cap structure in K2P channels. Front Physiol 7:228.